Selection of the method of renal revascularization in arteriosclerosis of the renal arteries

The work has analyzed results of 91 transaortal endarterectomies and 66 prostheses of renal arteries with the autovein. A preliminarily arterialized autovein is proposed as an autotransplant. The arterialization is achieved by inclusion of the autovein in the peripheral arterial system where the vein is gradually transformed and within 10-12 weeks its structure and biomechanical properties become closer to those of the artery of the musculo-elastic type. Preliminary arterialization excludes dilatatory changes of the autovenous transport.     

Naphthalimido derivatives as antifolate thymidylate synthase inhibitors

A new series of N-(substituted)benzyl-1,8-naphthalimides 4, structurally related to the previously reported thymidylate synthase (TS) inhibitor naphthaleins 3, were synthesized and compounds tested for their inhibition of several species of TS. Moreover, their in vitro cytotoxicity together with antimycotic and antibacterial properties were assayed. While no activity was detected in the antibacterial tests, the m-nitro (4ae) and the p-nitro (4af) derivatives were found able to partially inhibit TS at low micromolar concentrations. Introduction of nitro or (substituted)-amino groups in position 4 of the naphthalic ring always led to less active compounds.     

Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient

We report an instance of critical ovarian hyperstimulation syndrome in a highly responsive in-vitro fertilization patient despite the preventive measure of a 4 day 'coast' interval during which no gonadotrophins were administered while gonadotrophin-releasing hormone agonist therapy continued until serum oestradiol concentrations fell below 3000 pg/ml.      

Kinetics of hematopoietic stem cells in the bone marrow of hepatectomized mice

Two thirds of the liver was removed from (CBA×C57BL/6j)F₁ female mice. On the 5th day after the operation a significant increase was observed in the number of endogenous colonies in the spleen of the partially hepatectomized animals. This increase was not connected with a change in the number of stem cells in the bone marrow, for partial hepatectomy at different times after the operation did not affect the number of colony-forming units in the bone marrow.Laboratory of Virology, Oncologic Scientific Center, Academy of Medical Sciences of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR N. A. Kraevskii.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 85, No. 2, pp. 218–219, February, 1978.     

“Sokuluk” virus,a new group B arbovirus isolated from Vespertilio pipistrellus Schreber, 1775, bat in the Kirghiz S.S.R.

Summary A virus strain was isolated fromVespertilio pipistrellus Schreber, 1775 while examining bats in Sokuluksk region of the Kirghiz S.S.R. in 1970. Hemagglutination inhibition tests indicated that the virus ranged among group B arboviruses. It differed essentially in complement fixation and neutralization tests from 30 viruses of the B group: Entebbe bat; Bukalasa bat; Dakar bat; Kadam; Modoc; Spondweni; Ilheus; Japanese, St. Louis, Murray Vallay and tick-borne encephalitis; Kyasanur Forest disease; Powassan; Langat; Tyuleniy; West Nile; Bussuquara; Cowbone Ridge, Uganda S; SAH-336; Kokobera; yellow fever; Dengue, types 1 and 2; Wesselsbron; Edge Hill; Alfuy; Stratford; Zika; Potuskum. It may be concluded that Sokuluk virus is a new group B virus. Complement-fixing antibodies were not found in sera of 150 cows and 200 sheep but they were detected in 0.6 percent of 579 human sera in the Kirghiz S.S.R.     

The use of natural interferon alpha conjugated to a monoclonal antibody anti mammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts

Summary An immunoconjugate composed of natural interferon (nIFN) bound in a noncleavable fashion to a monoclonal antibody (MoAb) recognizing a breast epithelial membrane mucin (Mc5) was used to treat xenografts of a human mammary carcinoma cell line (MCF-7) growing in nude mice. The immunoconjugate (nIFN/Mc5) was administered as 20 intralesional (i.l.) injections to 1 of 2 xenografts in each animal. It was found that nIFN/Mc5 produced a significant enhancement of the growth inhibitory actions of nIFN on the injected tumors. Further enhancement was obtained when nIFN or nIFN together with Mc5 (at a dose 10 times larger than that present in nIFN/Mc5) were added to the immunoconjugate. Biodistribution experiments showed that the uptake of¹²⁵I-nIFN/Mc5 by the tumors was greater and its elimination slower than for¹²⁵I-nIFN alone or conjugated to irrelevant mouse IgG₁. In addition, the immunoconjugate up-regulated the antigenic expression of a breast epithelial membrane mucin by the carcinoma cells, an up-regulation which was not significantly different from that produced by nIFN alone. The contralateral noninjected tumors exposed to systemic levels of the immunoconjugate showed an enhancement of antitumor effects, but to a lesser extent than the injected tumors. These findings suggest that the enhancement of the growth inhibitory action of the immunoconjugate was related to the specific binding of Mc5 which targeted the IFN to the carcinoma cells and impeded its elimination. It is likely that the targeting was favored by the IFN-mediated up-regulation of antigenic expression by the carcinoma cells, thereby producing a cascade of interrelated effects. The results of this study point out the feasibility and potential usefulness of IFN treatment by means of immunoconjugates as well as the worth of pursuing and improving this form of therapy.